Prometheus Laboratories Inc.

We are excited to announce the execution of a provider agreement with three large regional health plans to facilitate access to PredictrPK®, precision-guided biologic testing, and other Prometheus testing services to participating health plans and their respective members. This agreement makes our testing services available within these three large regional health plans, representing five million members. Precision-guided biologic dosing to assess the right dose and right interval for each individual patient offers significant potential to reduce overall cost of care and waste related to failed biologic therapy and we are pleased to collaborate with forward-thinking health plans to advance value-driven care. https://lnkd.in/g8vE5uFT

❓Are you assessing ADA clearance for your IBD patients❓ Adult Crohn's disease patients with adalimumab clearance <0.318 L/day were more likely to have fecal calprotectin <100 µg/g and be in CRP-based clinical remission. 📄: https://lnkd.in/eReGYBHB #PrecisionMedicine #CrohnsDisease #Adalimumab #DrugClearance #ClinicalData #MedicalResearch #HealthcareInnovation #PatientCare #Gastroenterology #Biologics #PersonalizedMedicine #HealthOutcomes #EvidenceBasedMedicine #InnovationInHealthcare #HealthData

🚨New Pediatric Crohn's Infliximab Data🚨 Patients with clearance <0.294 L/day and optimized infusion 4 levels, via precision-guided dosing, were 3x more likely to achieve sustained CRP-based clinical remission vs. those with neither optimized CC: Elizabeth A. Spencer, MD, MS https://lnkd.in/eCkihYFU #Infliximab #CrohnsDisease #PrecisionMedicine #ClinicalData #MedicalResearch #HealthcareInnovation #Gastroenterology #PersonalizedMedicine #HealthOutcomes #EvidenceBasedMedicine #PatientManagement

We are excited to welcome Claudia Ibarra as Sr. Vice President of Lab Operations!   Claudia has over 30 years of experience in clinical laboratory operations, in the areas of immunology, oncology, and molecular biology. In her leadership roles, her teams grew vital operations capabilities of renowned diagnostic companies to a highly efficient and successful state focused on unparalleled quality, service and vendor management.   Welcome to the Prometheus Team, Claudia!

At #AMCP2024 real-world #HealthcareData found that #TherapeuticDrugMonitoring for #IFX optimization: • Mitigated loss of biologic response • Improved drug durability • Reduced #IBD-related surgeries • Improved health outcomes Full poster: https://bit.ly/449YwJr CC: Lynx.MD

At #AMCP2024 inflammatory bowel disease surgery rates & associated costs for #infliximab treated #IBD patients with dosing optimized via #TherapeuticDrugMonitoring will be shared. A collaboration w/ Lynx.MD that has significant impacts on #ManagedCare in #GI. #HealthcareFinance

Therapeutic drug monitoring to evaluate drug & antibody levels has applications across immune-mediated diseases. Saturday’s poster at the 2024 American Academy of Dermatology annual meeting shares how unique patient characteristics likely impact #IFX optimization and clinical response in #HidradenitisSuppurativa #Dermatology

Thrilled to see our CSO, Thierry Dervieux, inspiring the next generation of scientists and researchers at the 2024 San Diego Festival of Science & Engineering! A tremendous thanks to Jessica Ho, Director of R&D / Technical Operations on leading Prometheus’ involvement. Thank you ILLUMINA CORPORATE FOUNDATION for an amazing event and for all you do to make #STEM fun! #ScienceEd

Got plans today? Stop by Booth 32 at the San Diego Festival of Science & Engineering at Snapdragon Stadium! We welcome learners of all ages to learn about the procedures of a clinical lab through jellybeans!

Come see us at the San Diego Festival of Science & Engineering! We have a fun and interactive experiment for our young scientists to participate in! 🔬 #stem #science